The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy
Open accessAbstract
Cholangiocarcinomas are devastating cancers that are increasing in both their worldwide incidence and mortality rates. The challenges posed by these often lethal biliary tract cancers are daunting, with conventional treatment options being limited and the only hope for long-term survival being that of complete surgical resection of the tumor. Unfortunately, the vast majority of patients with cholangiocarcinoma typically seek treatment with advanced disease, and often these patients are deemed poor candidates for curative surgery. Moreover, conventional chemotherapy and radiation therapy have not been shown to be effective in prolonging long-term survival, and although photodynamic therapy combined with stenting has been reported to be effective as a palliative treatment, it is not curative. Thus, there is a real need to develop novel chemopreventive and adjuvant therapeutic strategies for cholangiocarcinoma based on exploiting select molecular targets that would impact in a significant way on clinical outcome. This review focuses on potential preventive targets in cholangiocarcinogenesis, such as inducible nitric oxide synthase, cyclooxygenase-2, and altered bile acid signaling pathways. In addition, molecular alterations related to dysregulation of cholangiocarcinoma cell growth and survival, aberrant gene expression, invasion and metastasis, and tumor microenvironment are described in the context of various clinical and pathological presentations. Moreover, an emphasis is placed on the importance of critical signaling pathways and postulated interactions, including those of ErbB-2, hepatocyte growth factor/Met, interleukin-6/glycoprotein130, cyclooxygenase-2, vascular endothelial growth factor, transforming growth factor-β, MUC1 and MUC4, β-catenin, telomerase, and Fas pathways as potential molecular therapeutic targets in cholangiocarcinoma. cholangiocarcinoma. (Hepatology 2005;41:5-15.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256
Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836
Jaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 653
Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study
Ortner, M. E. J., Caca, K., Berr, F., Liebetruth, J., Mansmann, U., Huster, D., Voderholzer, W., Schachschal, G., Mössner, J., & Lochs, H. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.015 · Cited by 608
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
Khan, S. A., Taylor-Robinson, S. D., Toledano, M. B., Beck, A., Elliott, P., & Thomas, H. C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00297-0 · Cited by 570
Pardi, D. S., Loftus, E. V., Kremers, W. K., Keach, J., & Lindor, K. D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50156 · Cited by 562
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998
Taylor-Robinson, S. D., Toledano, M. B., Arora, S., Keegan, T. J., Hargreaves, S., Beck, A., Khan, S. A., Elliott, P., & Thomas, H. C. (2001) · Gut · doi:10.1136/gut.48.6.816 · Cited by 381
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
Tannapfel, A., Sommerer, F., Benicke, M., Katalinic, A., Uhlmann, D., Witzigmann, H., Hauss, J., & Wittekind, C. (2003) · Gut · doi:10.1136/gut.52.5.706 · Cited by 343
Diagnosis and Treatment of Cholangiocarcinoma
Anderson, C. D., Wright Pinson, C., Berlin, J., & Chari, R. S. (2004) · The Oncologist · doi:10.1634/theoncologist.9-1-43 · Cited by 332
Monga, S. P., Mars, W. M., Pediaditakis, P., Bell, A. W., Mulé, K., Bowen, W. C., Wang, X., Zarnegar, R., & Michalopoulos, G. K. (2002) · PubMed · Cited by 304
Fukuda, R., Kelly, B., & Semenza, G. L. (2003) · PubMed · Cited by 294
Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.
Sell, S., & Dunsford, H. A. (1989) · Europe PMC (PubMed Central) · Cited by 290
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
Qiu, Y., Ravi, L., & Kung, H.-J. (1998) · Nature · doi:10.1038/30012 · Cited by 280
beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran, V., Lee, S. H., Inge, L. J., Guo, L., Goldbeck, C., Garrett, E. N., Wiesmann, M., García, P. D., Fuller, J. H., Chan, V. W.-F., et al. (2003) · PubMed · Cited by 279
COX-2 inhibition and colorectal cancer
Koehne, C.-H., & Dubois, R. N. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.041 · Cited by 273
Cholangiocarcinoma: Current Concepts and Insights
Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50200 · Cited by 272
A Review and Update on Cholangiocarcinoma
Olnes, M. J., & Erlich, R. (2004) · Oncology · doi:10.1159/000077991 · Cited by 266
Cell signaling through membrane mucins
Carraway, K. L., Ramsauer, V. P., Haq, B., & Carothers Carraway, C. A. (2003) · BioEssays · doi:10.1002/bies.10201 · Cited by 233
Rao, C. V., Cooma, I., Simi, B., Manning, P. T., Connor, J. R., & Reddy, B. S. (2002) · PubMed · Cited by 232
Nitric oxide–mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes
Jaiswal, M., LaRusso, N. F., Shapiro, R. A., Billiar, T. R., & Gores, G. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.20875 · Cited by 230
Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis
Singh, A. P., Moniaux, N., Chauhan, S. C., Meza, J. L., & Batra, S. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2636 · Cited by 229
Wang, X., DeFrances, M. C., Dai, Y., Pediaditakis, P., Johnson, C., Bell, A., Michalopoulos, G. K., & Zarnegar, R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00439-2 · Cited by 225
Regulation of Cyclooxygenase-2 pathway by HER2 receptor
Vadlamudi, R., Mandal, M., Adam, L., Steinbach, G., Mendelsohn, J., & Kumar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202307 · Cited by 222
DAWN, B. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.011 · Cited by 221
Hepatic ‘stem cell’ malignancies in adults: four cases
Theise, N. D., Yao, J. L., Harada, K., Hytiroglou, P., Portmann, B., Thung, S. N., Tsui, W., Ohta, H., & Nakanuma, Y. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01707.x · Cited by 207
Park, J., Tadlock, L., Gores, G. J., & Patel, T. (1999) · Hepatology · doi:10.1002/hep.510300522 · Cited by 206
Yoon, J., Higuchi, H., Werneburg, N. W., Kaufmann, S. H., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32410 · Cited by 193
Endo, K., Yoon, B.-I., Pairojkul, C., Demetris, A. J., & Sirica, A. E. (2002) · Hepatology · doi:10.1053/jhep.2002.34435 · Cited by 188
Self-citationTargeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth
Mann, M., Sheng, H., Shao, J., Williams, C. S., Dubois, R. N., Pisacane, P. I., & Sliwkowski, M. X. (2001) · Gastroenterology · doi:10.1053/gast.2001.24844 · Cited by 179
Pai, R., Nakamura, T., Moon, W. S., & Tarnawski, A. S. (2003) · The FASEB Journal · doi:10.1096/fj.02-1011com · Cited by 177
Date, K., Matsumoto, K., Kuba, K., Shimura, H., Tanaka, M., & Nakamura, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202231 · Cited by 176
MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion
Schroeder, J. A., Adriance, M. C., Thompson, M. C., Camenisch, T. D., & Gendler, S. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206291 · Cited by 173
Benckert, C., Jonas, S., Cramer, T., von Marschall, Z., Schäfer, G., Peters, M., Wagner, K., Radke, C., Wiedenmann, B., Neuhaus, P., et al. (2003) · PubMed · Cited by 164
COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells
Nzeako, U. C., Guicciardi, M. E., Yoon, J.-H., Bronk, S. F., & Gores, G. J. (2002) · Hepatology · doi:10.1053/jhep.2002.31774 · Cited by 163
c-erbB-2 Gene Product Associates with Catenins in Human Cancer Cells
Ochiai, A., Akimoto, S., Kanai, Y., Shibata, T., Oyama, T., & Hirohashi, S. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2631 · Cited by 162
Bile acids activate EGF receptor via a TGF-α-dependent mechanism in human cholangiocyte cell lines
Werneburg, N. W., Yoon, J., Higuchi, H., & Gores, G. J. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00536.2002 · Cited by 157
Tortora, G., Caputo, R., Damiano, V., Melisi, D., Bianco, R., Fontanini, G., Veneziani, B. M., Placido, S. D., Bianco, A. R., & Ciardiello, F. (2003) · PubMed · Cited by 150
Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
Hahn, S. A., Bartsch, D. K., Schroers, A., Galehdari, H., Becker, M. A., Ramaswamy, A., Schwarte‐Waldhoff, I., Maschek, H., & Schmiegel, W. (1998) · PubMed · Cited by 146
Differential Regulation of Tumor Angiogenesis by Distinct ErbB Homo- and Heterodimers
Yen, L., Benlimame, N., Nie, Z.-R., Xiao, D., Wang, T., Moustafa, A. A., Esumi, H., Milanini, J., Hynes, N. E., Pagès, G., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0084 · Cited by 146
Goueli, B. S., & Janknecht, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.25-35.2004 · Cited by 144
Cyclooxygenase-2 Promotes Human Cholangiocarcinoma Growth
Han, C. L., Leng, J., Demetris, A. J., & Wu, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1086 · Cited by 143
Haswell, M., Satarug, S., Tsuda, M., Mairiang, E., Esumi, H., Sithithaworn, P., Mairiang, P., Saitoh, M., Yongvanit, P., & Elkins, D. B. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90244-5 · Cited by 140
Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9.
Torok, N. J., Higuchi, H., Bronk, S. F., & Gores, G. J. (2002) · PubMed · Cited by 139
Spirlì, C., Fabris, L., Duner, E., Fiorotto, R., Ballardini, G., Roskams, T., LaRusso, N. F., Sonzogni, A., Okolicsànyi, L., & Strazzabosco, M. (2003) · Gastroenterology · doi:10.1053/gast.2003.50100 · Cited by 138
Subramanian, G., Schwarz, R. E., Higgins, L., McEnroe, G., Chakravarty, S., Dugar, S., & Reiss, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0018 · Cited by 138
Ohashi, K., Nakajima, Y., Kanehiro, H., Tsutsumi, M., Taki, J., Aomatsu, Y., Yoshimura, A., Ko, S., Kin, T., Yagura, K., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90650-9 · Cited by 135
Hayashi, N., Yamamoto, H., Hiraoka, N., Dono, K., Ito, Y., Okami, J., Kondo, M., Nagano, H., Umeshita, K., Sakon, M., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.28198 · Cited by 135
Terada, T., Nakanuma, Y., & Sirica, A. E. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90229-5 · Cited by 133
Self-citationYokomuro, S., Tsuji, H., Lunz, J. G., Sakamoto, T., Ezure, T., Murase, N., & Demetris, A. J. (2000) · Hepatology · doi:10.1053/jhep.2000.8535 · Cited by 129
Eibl, G., Bruemmer, D., Okada, Y., Duffy, J. P., Law, R. E., Reber, H. A., & Hines, O. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01079-9 · Cited by 123
Anatomic and molecular pathology of intrahepatic cholangiocarcinoma
Nakanuma, Y., Harada, K., Ishikawa, A., Zen, Y., & Sasaki, M. (2003) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-002-0729-3 · Cited by 121
Zhang, Z., Lai, G., & Sirica, A. E. (2004) · Hepatology · doi:10.1002/hep.20143 · Cited by 120
Self-citationArgani, P., Shaukat, A., Kaushal, M., Wilentz, R. E., Su, G. H., Riall, T. S., Yeo, C. J., Cameron, J. L., Kern, S. E., & Hruban, R. H. (2001) · Cancer · doi:10.1002/1097-0142(20010401)91:7<1332::aid-cncr1136>3.3.co;2-w · Cited by 117
Aishima, S., Taguchi, K., Sugimachi, K., Shimada, M., Sugimachi, K., & Tsuneyoshi, M. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.00353.x · Cited by 116
Mechanisms of biliary carcinogenesis: A pathogenetic multi-stage cascade towards cholangiocarcinoma
Holzinger, F., Z’graggen, K., & Büchler, M. W. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s122 · Cited by 110
Liu, X., Kirschenbaum, A. M., Lü, M., Shen, Y., Klausner, A. P., Preston, C., Holland, J. F., & Levine, A. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6188 · Cited by 102
Ashida, K., Terada, T., Kitamura, Y., & Kaibara, N. (1998) · Hepatology · doi:10.1002/hep.510270412 · Cited by 101
Yoon, J., Canbay, A. E., Werneburg, N. W., Lee, S. P., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20125 · Cited by 96
Isa, T., Tomita, S., Nakachi, A., Miyazato, H., Shimoji, H., Kusano, T., Muto, Y., & Furukawa, M. (2002) · PubMed · Cited by 93
Taniai, M., Higuchi, H., Burgart, L. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36021 · Cited by 93
Human Wisp1v, A Member of the Ccn Family, Is Associated With Invasive Cholangiocarcinoma
Tanaka, S., Sugimachi, K., 亀山, 敏., Maehara, S., Shirabe, K., Shimada, M., Wands, J. R., & Maehara, Y. (2003) · Hepatology · doi:10.1053/jhep.2003.50187 · Cited by 86
Cellular and molecular biology of biliary tract cancers
Rashid, A. (2002) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00042-x · Cited by 85
Yoon, J., Werneburg, N. W., Higuchi, H., Canbay, A. E., Kaufmann, S. H., Akgul, C., Edwards, S. W., & Gores, G. J. (2002) · PubMed · Cited by 83
Ahn, E.-Y. E., Pan, G., Vickers, S. M., & McDonald, J. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10516 · Cited by 83
Bockhorn, M., Tsuzuki, Y., Xu, L., Frilling, A., Broelsch, C. E., & Fukumura, D. (2003) · PubMed · Cited by 82
Ishikawa, A., Sasaki, M., Ohira, S., Ohta, T., Oda, K., Nimura, Y., Chen, M., Jan, Y.-Y., Yeh, T., & Nakanuma, Y. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700087 · Cited by 81
Han, C. L., Demetris, J. A., Michalopoulos, G. K., Zhan, Q., Shelhamer, J. H., & Wu, T. (2003) · Hepatology · doi:10.1053/jhep.2003.50296 · Cited by 78
Matsumura, N., Yamamoto, M., Aruga, A., Takasaki, K., & Nakano, M. (2002) · Cancer · doi:10.1002/cncr.10398 · Cited by 77
Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2
Benoît, V., Relić, B., de Leval, X., Chariot, A., Merville, M., & Bours, V. (2004) · Oncogene · doi:10.1038/sj.onc.1207295 · Cited by 76
Pro-inflammatory Cytokines Up-regulate MUC1 Gene Expression in Oral Epithelial Cells
Li, X., Wang, L., Nunes, D. P., et al. (2003) · Journal of Dental Research · doi:10.1177/154405910308201107 · Cited by 75
Elmore, L. W., & Sirica, A. E. (1993) · PubMed · Cited by 74
Self-citationWu, T., Han, C. L., Lunz, J. G., Michalopoulos, G. K., Shelhamer, J. H., & Demetris, J. A. (2002) · Hepatology · doi:10.1053/jhep.2002.34743 · Cited by 73
Shammas, M. A., Koley, H., Beer, D. G., Li, C., Goyal, R. K., & Munshi, N. C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.026 · Cited by 70
Alpini, G. D., Kanno, N., Phinizy, J. L., Glaser, S. S., Francis, H., Taffetani, S., & LeSage, G. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00270.2003 · Cited by 70
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Intrahepatic cholangiocarcinoma: indication for transplantation
Pascher, A., Jonas, S., & Neuhaus, P. (2003) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-002-0731-9 · Cited by 66
Ishimura, N., Bronk, S. F., & Gores, G. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00539.2003 · Cited by 66
Grant, S. L., Hammacher, A., Douglas, A. M., Goss, G. A., Mansfield, R., Heath, J. K., & Begley, C. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205100 · Cited by 64
Herynk, M. H., Tsan, R., Radinsky, R., & Gallick, G. E. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1024024218529 · Cited by 61
Chen, T., Nines, R. G., Peschke, S. M., Kresty, L. A., & Stoner, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0302 · Cited by 56
Park, Y., Kang, S., Kim, W.-J., Lee, Y.-C., & Kim, C. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.019 · Cited by 53
Wang, J., Torbenson, M. S., Wang, Q. I., Ro, J. Y., & Becich, M. J. (2003) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(02)00208-9 · Cited by 51
Lai, G., Radaeva, S., Nakamura, T., & Sirica, A. E. (2000) · Hepatology · doi:10.1053/jhep.2000.8108 · Cited by 47
Self-citationKi-ras point mutations and proliferation activity in biliary tract carcinomas
Ohashi, K., Tstsumi, M., Nakajima, Y., Nakano, H., & Konishi, Y. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.459 · Cited by 44
Expression and Antitumor Effects of TRAIL in Human Cholangiocarcinoma
Tanaka, S., Sugimachi, K., Shirabe, K., Shimada, M., Wands, J. R., & Sugimachi, K. (2000) · Hepatology · doi:10.1053/jhep.2000.9716 · Cited by 44
The suppression of colon cancer cell growth in nude mice by targetingβ-catenin/TCF pathway
Kwong, K. Y., Zou, Y., Day, C., & Hung, M. (2002) · Oncogene · doi:10.1038/sj.onc.1206050 · Cited by 39
Acute Cholestatic Hepatitis Associated with Celecoxib
Grieco, A., Miele, L., Giorgi, A., Civello, I. M., & Gasbarrini, A. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1c110 · Cited by 37
Ito, Y., Takeda, T., Sasaki, Y., et al. (2000) · Oncology · doi:10.1159/000012139 · Cited by 34
Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS)
Hüster, D., Schubert, C., Berr, F., Mössner, J., & Caca, K. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00177-0 · Cited by 32
Ozaki, S., Harada, K., Sanzen, T., Watanabe, K., Tsui, W. M. S., & Nakanuma, Y. (1999) · Hepatology · doi:10.1002/hep.510300419 · Cited by 31
Nagi, P. A., Vickers, S. M., Davydova, J., Adachi, Y., Takayama, K., Barker, S., Krasnykh, V. N., Curiel, D. T., & Yamamoto, M. (2003) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(02)00437-7 · Cited by 24
Ito, Y., Takeda, T., Sasaki, Y., Sakon, M., Yamada, T., Ishiguro, S., Imaoka, S., Tsujimoto, M., & Matsuura∥, N. (2001) · Oncology · doi:10.1159/000055325 · Cited by 23
Regulation of MUC1 Expression in Human Mammary Cell Lines by the c-ErbB2 and Ras Signaling Pathways
Scibetta, A. G., Albanese, I., Morris, J. R., Cooper, L., Downward, J., Pitha-Rowe, P. M., & Taylor‐Papadimitriou, J. (2001) · DNA and Cell Biology · doi:10.1089/104454901750232463 · Cited by 20
Okano, H., Shiraki, K., Inoue, H., Kawakita, T., Deguchi, M., Sugimoto, K., Sakai, T., Murata, K., Nakano, T., & Enjoji, M. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.12.6.867 · Cited by 11
Yamamoto, K., Katayose, Y., Suzuki, M., Unno, M., Sasaki, T., Mizuma, M., Shiraso, S., Ohtuka, H., Cowan, K. H., Seth, P. K., et al. (2003) · PubMed · Cited by 10
Cited by
Liver Fluke Induces Cholangiocarcinoma
Sripa, B., Kaewkes, S., Sithithaworn, P., Mairiang, E., Laha, T., Smout, M., Pairojkul, C., Bhudhisawasdi, V., Tesana, S., Thinkamrop, B., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040201 · Cited by 775
Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities
Mocellin, S., Bronte, V., & Nitti, D. (2007) · Medicinal Research Reviews · doi:10.1002/med.20092 · Cited by 478
Yoshikawa, D., Ojima, H., Iwasaki, M., Hiraoka, N., Kosuge, T., Kasai, S., Hirohashi, S., & Shibata, T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604129 · Cited by 404
Phase II Study of Erlotinib in Patients With Advanced Biliary Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3579 · Cited by 318
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
Aljiffry, M., Walsh, M. J., & Molinari, M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4240 · Cited by 286
Metadata
- Authors
- Sirica, A. E.
- Venue
- Hepatology
- Published
- 2005-01
- Volume
- 41
- Issue
- 1
- Pages
- 5-15
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2054566387
- Cited by
- 315
- References
- 96
- FWCI
- 17.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.